Guerbet () is a

France France (), officially the French Republic ( ), is a country primarily located in Western Europe. It also comprises of Overseas France, overseas regions and territories in the Americas and the Atlantic Ocean, Atlantic, Pacific Ocean, Pac ...

-based manufacturer of

contrast agent A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiop ...

s used in

medical imaging Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Medical imaging seeks to rev ...

. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered

Lipiodol Lipiodol, also known as ethiodized oil, is a poppyseed oil used by Injection (medicine), injection as a radio-opaque contrast agent that is used to outline structures in radiological investigations. It is used in Transcatheter arterial chemoemboli ...

– the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the

United States The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 states, a federal district, five major unincorporated territorie ...

and

Brazil Brazil ( pt, Brasil; ), officially the Federative Republic of Brazil (Portuguese: ), is the largest country in both South America and Latin America. At and with over 217 million people, Brazil is the world's fifth-largest country by area ...

. The company’s headquarters are located in Villepinte, a suburb of

Paris Paris () is the capital and most populous city of France, with an estimated population of 2,165,423 residents in 2019 in an area of more than 105 km² (41 sq mi), making it the 30th most densely populated city in the world in 2020. S ...

and its shares are included in the

CAC Small The CAC Small (formerly the CAC Small 90) is a stock market index used by the Paris Bourse. It is a small-cap index which represents all main-market French equities not included in the CAC 40, the CAC Next 20 or the CAC Mid 60. Together, these 4 in ...

stock index. In July 2015, Guerbet announced the takeover of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015.

References

External links

* Healthcare companies of France Health care companies established in 1926 French companies established in 1926 Companies listed on Euronext Paris {{France-company-stub